Glenmark Pharma

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE935A01035
NSEID: GLENMARK
BSEID: 532296

INR

1,370.20

-6.15 (-0.45%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.46 lacs

{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,370.20",
    "chg": -6.15,
    "chgp": "-0.45%",
    "dir": -1,
    "prev_price": "1,376.35",
    "mcapval": "38,665.42 Cr",
    "mcap": "Large Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE935A01035",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:24 AM",
    "bse_nse_vol": "4.46 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glenmark Pharmaceuticals Exhibits Strong Performance Amid Market Volatility and Sector Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-stock-rises-3-03-outperforming-broader-market-trends-1693389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/GlenmarkPharmac_priceRelatedfactors_882938.png",
        "date": "2025-04-03 09:30:36",
        "description": "Glenmark Pharmaceuticals has demonstrated strong performance, gaining 3.03% today and achieving a total return of 3.53% over the last two days. The stock has shown high volatility and is trading above key moving averages, with impressive long-term growth compared to the broader market."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-11-21-surge-in-open-interest-amid-active-trading-1646471",
        "imagepath": "",
        "date": "2025-03-28 15:00:28",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 20,871 contracts, up from the previous 18,768, marking a change of 2,103 contracts or an 11.21% increase. The trading volume for the day reached 15,520 contracts, contributing to a futures value of approximately Rs 17,526.95 lakhs.\n\nIn terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.76%, with a stock return of 1.59% for the day. The stock has shown consistent gains over the past two days, accumulating a total return of 5.44% during this period. Notably, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.\n\nAdditionally, the stock has seen a remarkable rise in delivery volume, which reached 12.49 lakh shares on March 27, reflecting a 205.21%..."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-10-12-rise-in-open-interest-amid-increased-trading-activity-1644975",
        "imagepath": "",
        "date": "2025-03-28 14:00:26",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 20,667 contracts, up from the previous figure of 18,768, marking a change of 1,899 contracts or a 10.12% increase. The trading volume for the day reached 13,543 contracts, indicating robust participation in the market.\n\nIn terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.44%, with a 1D return of 0.85%. The stock has shown consistent gains over the past two days, accumulating a total return of 4.94% during this period. Notably, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend.\n\nAdditionally, the stock's delivery volume on March 27 was recorded at 124,900 shares, reflecting a substantial increase of 205.21% compared to the 5-da..."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-10-14-surge-in-open-interest-amid-increased-trading-activity-1642115",
        "imagepath": "",
        "date": "2025-03-28 12:00:26",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a notable increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 20,671 contracts, up from the previous 18,768 contracts, marking a change of 1,903 contracts or a 10.14% increase. The trading volume for the day reached 11,237 contracts, contributing to a futures value of approximately Rs 12,742.67 lakhs and an options value of around Rs 4,448.10 crores, bringing the total value to Rs 13,971.48 lakhs.\n\nIn terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.29%, with a 1D return of 0.88%. The stock has shown consistent gains over the past two days, accumulating a total return of 5.08%. Additionally, Glenmark is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.\n\nThe stock's liquidity remains robust, with a de..."
      },
      {
        "title": "Glenmark Pharmaceuticals Shows Trend Reversal Amidst Dynamic Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-stock-rises-3-28-after-three-days-of-decline-1629372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GlenmarkPharmac_priceRelatedfactors_827903.png",
        "date": "2025-03-27 15:05:26",
        "description": "Glenmark Pharmaceuticals has reversed a three-day decline, gaining 3.28% on March 27, 2025. The stock has outperformed its sector today and has shown strong monthly growth. Despite a recent three-month decline, it boasts impressive long-term gains over the past three and five years in the pharmaceuticals sector."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-22-7-surge-in-open-interest-amid-increased-trading-activity-1586695",
        "imagepath": "",
        "date": "2025-03-25 15:00:49",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 36,394 contracts, up from the previous 29,660 contracts, marking a change of 6,734 contracts or a 22.7% increase. The trading volume for the day reached 23,753 contracts, contributing to a total futures value of approximately Rs 70.66 crore.\n\nIn terms of price performance, Glenmark Pharmaceuticals has outperformed its sector by 0.28%, despite a recent decline, with the stock down 0.74% today and having fallen 2.23% over the last two days. The stock is currently trading above its 5-day, 20-day, and 50-day moving averages, but below its 100-day and 200-day moving averages, indicating mixed short to medium-term trends.\n\nAdditionally, the stock has shown rising investor participation, with a delivery volume of 636,000 shares on March 24, r..."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-21-7-surge-in-open-interest-reaching-36095-contracts-1584912",
        "imagepath": "",
        "date": "2025-03-25 14:00:35",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 36,095 contracts, up from the previous 29,660, marking a change of 6,435 contracts or a 21.7% increase. The trading volume for the stock reached 22,413 contracts, contributing to a total futures value of approximately Rs 66,286 lakhs.\n\nIn terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 0.58%, despite facing a decline of 2.26% over the last two days. The stock's weighted average price indicates that more volume was traded closer to its low price, suggesting a shift in trading dynamics. While the stock remains above its 5-day, 20-day, and 50-day moving averages, it is currently below its 100-day and 200-day moving averages.\n\nAdditionally, the stock has seen a notable rise in delivery volume, which increased ..."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-19-84-surge-in-open-interest-reaching-35546-contracts-1583191",
        "imagepath": "",
        "date": "2025-03-25 13:00:23",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 35,546, up from the previous figure of 29,660, marking a change of 5,886, or a 19.84% increase. The trading volume for the day reached 20,341, contributing to a futures value of approximately Rs 59,710.91 lakhs and an options value of Rs 3,872.44 crores, bringing the total value to Rs 60,110.52 lakhs.\n\nIn terms of price performance, Glenmark Pharmaceuticals has outperformed its sector by 0.7%, despite a consecutive decline over the past two days, resulting in a total return of -2.15%. The stock's weighted average price indicates that more volume was traded closer to its low price. While the stock remains above its 5-day, 20-day, and 50-day moving averages, it is trading below its 100-day and 200-day moving averages.\n\nAdditionally..."
      },
      {
        "title": "Glenmark Pharmaceuticals Shows Mixed Technical Trends Amidst Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-volatility-1287783",
        "imagepath": "",
        "date": "2025-03-11 08:03:27",
        "description": "Glenmark Pharmaceuticals, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1,395.55, slightly down from the previous close of 1,401.50. Over the past year, Glenmark has demonstrated notable resilience, with a return of 46.22%, significantly outperforming the Sensex, which remained virtually unchanged.\n\nIn terms of technical indicators, the company shows a mixed picture. The MACD indicates a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Bollinger Bands present a contrasting view, with a bullish signal on the monthly chart. Moving averages and KST metrics also reflect bearish tendencies, while the Dow Theory suggests a mildly bullish stance on a weekly basis.\n\nGlenmark's performance over various time frames highlights its volatility. For instance..."
      }
    ],
    "total": 200,
    "sid": "780863",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "07-Apr-2025",
      "details": "Appointment of Senior Management Personnel of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Apr-2025",
      "details": "Glenmark Pharmaceuticals Inc. USA launches Vancomycin Hydrochloride for Injection USP 750 mg/vial 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-Mar-2025",
      "details": "Newspaper Advertisement of Postal Ballot Notice",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 13 Sep 24",
          "dt": "2024-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glenmark Pharmaceuticals Exhibits Strong Performance Amid Market Volatility and Sector Gains

2025-04-03 09:30:36

Glenmark Pharmaceuticals has demonstrated strong performance, gaining 3.03% today and achieving a total return of 3.53% over the last two days. The stock has shown high volatility and is trading above key moving averages, with impressive long-term growth compared to the broader market.

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-28 15:00:28

Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 20,871 contracts, up from the previous 18,768, marking a change of 2,103 contracts or an 11.21% increase. The trading volume for the day reached 15,520 contracts, contributing to a futures value of approximately Rs 17,526.95 lakhs. In terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.76%, with a stock return of 1.59% for the day. The stock has shown consistent gains over the past two days, accumulating a total return of 5.44% during this period. Notably, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Additionally, the stock has seen a remarkable rise in delivery volume, which reached 12.49 lakh shares on March 27, reflecting a 205.21%...

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-28 14:00:26

Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 20,667 contracts, up from the previous figure of 18,768, marking a change of 1,899 contracts or a 10.12% increase. The trading volume for the day reached 13,543 contracts, indicating robust participation in the market. In terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.44%, with a 1D return of 0.85%. The stock has shown consistent gains over the past two days, accumulating a total return of 4.94% during this period. Notably, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. Additionally, the stock's delivery volume on March 27 was recorded at 124,900 shares, reflecting a substantial increase of 205.21% compared to the 5-da...

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-28 12:00:26

Glenmark Pharmaceuticals Ltd. has experienced a notable increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 20,671 contracts, up from the previous 18,768 contracts, marking a change of 1,903 contracts or a 10.14% increase. The trading volume for the day reached 11,237 contracts, contributing to a futures value of approximately Rs 12,742.67 lakhs and an options value of around Rs 4,448.10 crores, bringing the total value to Rs 13,971.48 lakhs. In terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 1.29%, with a 1D return of 0.88%. The stock has shown consistent gains over the past two days, accumulating a total return of 5.08%. Additionally, Glenmark is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. The stock's liquidity remains robust, with a de...

Glenmark Pharmaceuticals Shows Trend Reversal Amidst Dynamic Market Conditions

2025-03-27 15:05:26

Glenmark Pharmaceuticals has reversed a three-day decline, gaining 3.28% on March 27, 2025. The stock has outperformed its sector today and has shown strong monthly growth. Despite a recent three-month decline, it boasts impressive long-term gains over the past three and five years in the pharmaceuticals sector.

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-25 15:00:49

Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 36,394 contracts, up from the previous 29,660 contracts, marking a change of 6,734 contracts or a 22.7% increase. The trading volume for the day reached 23,753 contracts, contributing to a total futures value of approximately Rs 70.66 crore. In terms of price performance, Glenmark Pharmaceuticals has outperformed its sector by 0.28%, despite a recent decline, with the stock down 0.74% today and having fallen 2.23% over the last two days. The stock is currently trading above its 5-day, 20-day, and 50-day moving averages, but below its 100-day and 200-day moving averages, indicating mixed short to medium-term trends. Additionally, the stock has shown rising investor participation, with a delivery volume of 636,000 shares on March 24, r...

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-25 14:00:35

Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 36,095 contracts, up from the previous 29,660, marking a change of 6,435 contracts or a 21.7% increase. The trading volume for the stock reached 22,413 contracts, contributing to a total futures value of approximately Rs 66,286 lakhs. In terms of performance, Glenmark Pharmaceuticals has outperformed its sector by 0.58%, despite facing a decline of 2.26% over the last two days. The stock's weighted average price indicates that more volume was traded closer to its low price, suggesting a shift in trading dynamics. While the stock remains above its 5-day, 20-day, and 50-day moving averages, it is currently below its 100-day and 200-day moving averages. Additionally, the stock has seen a notable rise in delivery volume, which increased ...

Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Increased Trading Activity

2025-03-25 13:00:23

Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 35,546, up from the previous figure of 29,660, marking a change of 5,886, or a 19.84% increase. The trading volume for the day reached 20,341, contributing to a futures value of approximately Rs 59,710.91 lakhs and an options value of Rs 3,872.44 crores, bringing the total value to Rs 60,110.52 lakhs. In terms of price performance, Glenmark Pharmaceuticals has outperformed its sector by 0.7%, despite a consecutive decline over the past two days, resulting in a total return of -2.15%. The stock's weighted average price indicates that more volume was traded closer to its low price. While the stock remains above its 5-day, 20-day, and 50-day moving averages, it is trading below its 100-day and 200-day moving averages. Additionally...

Glenmark Pharmaceuticals Shows Mixed Technical Trends Amidst Strong Long-Term Performance

2025-03-11 08:03:27

Glenmark Pharmaceuticals, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1,395.55, slightly down from the previous close of 1,401.50. Over the past year, Glenmark has demonstrated notable resilience, with a return of 46.22%, significantly outperforming the Sensex, which remained virtually unchanged. In terms of technical indicators, the company shows a mixed picture. The MACD indicates a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Bollinger Bands present a contrasting view, with a bullish signal on the monthly chart. Moving averages and KST metrics also reflect bearish tendencies, while the Dow Theory suggests a mildly bullish stance on a weekly basis. Glenmark's performance over various time frames highlights its volatility. For instance...

View All News